These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28391884)

  • 1. Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.
    Koller L; Richter B; Winter MP; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Lang I; Wojta J; Hülsmann M; Niessner A
    J Clin Lipidol; 2017; 11(1):178-184. PubMed ID: 28391884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.
    Turkieh A; Fertin M; Bouvet M; Mulder P; Drobecq H; Lemesle G; Lamblin N; de Groote P; Porouchani S; Chwastyniak M; Beseme O; Amouyel P; Mouquet F; Balligand JL; Richard V; Bauters C; Pinet F
    Circ Heart Fail; 2018 Jun; 11(6):e004838. PubMed ID: 29891738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin serum level: how does it affect psoriatic patients?
    Buquicchio R; Foti C; Loconsole F; Polimeno L; Ventura MT
    J Biol Regul Homeost Agents; 2017; 31(3):785-789. PubMed ID: 28958138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.
    Koller L; Kleber ME; Brandenburg VM; Goliasch G; Richter B; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; Berger R; Mörtl D; Hülsmann M; Pacher R; März W; Niessner A
    Circ Heart Fail; 2015 Nov; 8(6):1059-67. PubMed ID: 26273098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
    Rychli K; Richter B; Hohensinner PJ; Kariem Mahdy A; Neuhold S; Zorn G; Berger R; Mörtl D; Huber K; Pacher R; Wojta J; Niessner A; Hülsmann M
    Heart; 2011 Jul; 97(14):1158-63. PubMed ID: 21572126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression levels of the senescence biomarker clusterin/apolipoprotein j in lymphocytes from healthy centenarians.
    Trougakos IP; Petropoulou C; Franceschi C; Gonos ES
    Ann N Y Acad Sci; 2006 May; 1067():294-300. PubMed ID: 16804001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein Proteomic Profiling for the Prediction of Cardiovascular Death in Patients with Heart Failure.
    Lemesle G; Chouraki V; de Groote P; Turkieh A; Beseme O; Drobecq H; Amouyel P; Lamblin N; Bauters C; Pinet F
    Proteomics Clin Appl; 2020 Nov; 14(6):e2000035. PubMed ID: 32918783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary assessment of serum clusterin as a potential biomarker for canine lymphoma.
    McNaught KA; Morris JS; McLaughlin M
    Vet Comp Oncol; 2020 Sep; 18(3):292-302. PubMed ID: 31654603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma clusterin and the risk of Alzheimer disease.
    Schrijvers EM; Koudstaal PJ; Hofman A; Breteler MM
    JAMA; 2011 Apr; 305(13):1322-6. PubMed ID: 21467285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
    Richter B; Koller L; Hohensinner PJ; Rychli K; Zorn G; Goliasch G; Berger R; Mörtl D; Maurer G; Huber K; Pacher R; Wojta J; Hülsmann M; Niessner A
    Thromb Haemost; 2012 Dec; 108(6):1220-7. PubMed ID: 23014777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O;
    Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.
    Latini R; Gullestad L; Masson S; Nymo SH; Ueland T; Cuccovillo I; Vårdal M; Bottazzi B; Mantovani A; Lucci D; Masuda N; Sudo Y; Wikstrand J; Tognoni G; Aukrust P; Tavazzi L;
    Eur J Heart Fail; 2012 Sep; 14(9):992-9. PubMed ID: 22740508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.
    Trougakos IP
    Gerontology; 2013; 59(6):514-23. PubMed ID: 23689375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of thyroid function on clinical outcome in patients with heart failure.
    Chen S; Shauer A; Zwas DR; Lotan C; Keren A; Gotsman I
    Eur J Heart Fail; 2014 Feb; 16(2):217-26. PubMed ID: 24464626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic relevance of circulating endothelial progenitor cells in patients with chronic heart failure.
    Koller L; Hohensinner P; Sulzgruber P; Blum S; Maurer G; Wojta J; Hülsmann M; Niessner A
    Thromb Haemost; 2016 Aug; 116(2):309-16. PubMed ID: 27412580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of clusterin/apolipoprotein J on cellular growth and survival.
    Trougakos IP; Lourda M; Agiostratidou G; Kletsas D; Gonos ES
    Free Radic Biol Med; 2005 Feb; 38(4):436-49. PubMed ID: 15649646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria.
    Magrì D; Corrà U; Di Lenarda A; Cattadori G; Maruotti A; Iorio A; Mezzani A; Giannuzzi P; Mantegazza V; Gondoni E; Sinagra G; Piepoli MF; Fiorentini C; Agostoni P
    Eur J Heart Fail; 2014 Feb; 16(2):201-9. PubMed ID: 24464973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.